S
Sol-Gel Technologies Ltd D
D
SLGL
64.370
USD
-3.33
(-4.92%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
1,159
الربح لكل سهم
-6
العائد الربحي
-
P/E
-11
حجم السوق
210,747,316
العنوان: Sol/Gel Technologies Ltd
القطاع: الرعاية الصحية
الصناعة: Biotechnology
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includesSGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease andother rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.















